Concrete Plus buys additional stake in Rameda for EGP 2.6M

Updated 8/28/2022 8:53:01 AM

Arab Finance: Concrete Plus for Engineering and Construction has purchased a further stake in Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) of 940,000 shares at a total value of EGP 2.62 million, according to a disclosure to the Egyptian Exchange (EGX) on August 25th.

Accordingly, Concrete Plus has raised its stake in Rameda to 5.017% from 4.92%.

The transaction was executed at an average price of EGP 2.792 per share.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms.